ADC Therapeutics S.A.ADCTNYSE
LOADING
|||
Switch Symbol:
EBITDA Over Time
Trending higher, above historical average.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-102.65M
↑ 28% above average
Average (7y)
$-141.59M
Historical baseline
Range
High:$-91.33M
Low:$-230.53M
CAGR
+1.7%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-102.65M | +29.6% |
| 2023 | $-145.83M | -35.4% |
| 2022 | $-107.70M | +53.3% |
| 2021 | $-230.53M | -5.6% |
| 2020 | $-218.23M | -91.3% |
| 2019 | $-114.10M | +6.7% |
| 2018 | $-122.36M | -34.0% |
| 2017 | $-91.33M | - |